A training system for badminton players utilizing artificial intelligence (AI) that was developed by university researchers and Victor Rackets Industrial Corp is being tested at a Tainan high school, researchers told a news conference at the Ministry of Science and Technology in Taipei yesterday.
Designed to give customized training to athletes, the system combines image recognition, racket motion trajectory, biosignal analysis and a cloud platform for data analysis, they said.
The system is comprised of a badminton racket with a built-in sensor for recording motion, a smart watch, a brainwave sensor and a camera attached to goggles to record biosignals, said Tsai Chia-liang (蔡佳良), director of National Cheng Kung University’s (NCKU) Institute of Physical Education.
The sensor in the racket initally weighed 9.5g, but Victor Rackets was able to optimize the design of the racket handle to keep the weight to within 6g, Tsai said.
The system has been tested by badminton players at National Hsin-Feng Senior High School in Tainan, home to badminton teams that have won several national competitions, he said.
The research team created an experimental field at the school equipped with cameras to capture players’ movements, said Wang Jeen-shing (王振興), a professor in NCKU’s department of electrical engineering.
Reading collected signals through machine learning and integrating all the functions to yield precise analyses were the main goals for developing the system, Wang said, adding that the researchers hope the system will be used by professional players.
To protect players’ personal data, each smart racket has an identification code, but Victor Rackets might later include encrypted information protection services for different levels of players, he added.
Hsin-Feng badminton coach Lee Yi-hsun (李宜勳) said the system allows her to better understand her players’ physical condition, and the students have been inspired by the devices to work harder to improve their performance.
Victor Taiwan marketing and sales division deputy director Elvis Ke (柯泓全) presented the high school with 45 smart rackets during the news conference.
The company’s main competitors in developing smart rackets are Chinese brands, but it is confident that it will gain the upper hand, Ke said.
While the antiparasitic drug ivermectin is being touted as a treatment for COVID-19 in many parts of the world, Taiwanese experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence. “Following an experts’ meeting, we do not recommend regular use of ivermectin in treating COVID-19 due to the lack of enough evidence,” said Chang Shan-chwen (張上淳), convener of the Central Epidemic Command Center’s (CECC) expert advisory panel. A report in the American Journal of Therapeutics said that meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 patients had found large,
CLASSES HALTED: Cram schools have had to return tuition fees due to mandatory closures and might need to lay off half of their staff because of a lack of revenue The COVID-19 pandemic has taken a toll on the education sector, with some cram schools and tutoring centers saying they might soon be unable to pay their instructors due to the extension of a nationwide level 3 COVID-19 alert. The heightened alert level means schools must remain closed, so cram schools and tutoring centers have had to return tuition fees, one cram school said. June is normally the peak season for recruiting new students at cram schools and tutoring centers, but this year many such schools might need to lay off half of their staff due to a lack of
A person who was on Friday reported as the first in Taiwan to die after receiving a COVID-19 vaccine died of a heart attack, a Central Epidemic Command Center (CECC) official said yesterday. The deceased, whose sex and age were not disclosed, had coronary artery disease, which led to a fatal heart attack, Centers for Disease Control Deputy Director-General Chuang Jen-hsiang (莊人祥), who is the CECC’s spokesman, told a news conference, citing the autopsy report. It was the first death listed as a possible adverse event after receiving the AstraZenenca COVID-19 vaccine since the start of the vaccination program on March 22. The
PARTY LINES: Just 28.1% of respondents said they were willing to get a local vaccine, including 52.8% of DPP voters and 48.6% of Taiwan Statebuilding Party voters Sixty-two percent of Taiwanese disapprove of the Central Epidemic Command Center’s (CECC) progress in obtaining COVID-19 vaccines, while 65.6 percent said that they would not take domestic vaccines that lack WHO certification, a poll released yesterday by Trend Survey and Research and commissioned by the Taiwan People’s Party (TPP) found. Trend Survey general manager Wu Shih-chang (吳世昌) announced the results of the survey with TPP officials at a virtual news conference, adding that 41.3 percent of respondents said that they highly disapproved of the center’s efforts to secure vaccines. About 68.6 percent of the respondents agreed that the country should rely on